
UEG Journal podcast Episode 12- Advances in GI disease: biomarkers, treatment outcomes, and cost-effectiveness of EUS-GE
Notas del episodio
Linking molecular diagnostics, real-world IBD therapy data, and health-economic evidence in gastric cancer and Crohn’s disease care
Article link
- Molecular Traces of Gastric Cancer in Saliva: From Tissue Signatures to Salivary SLC5A5 as a Potential Biomarker
https://onlinelibrary.wiley.com/doi/full/10.1002/ueg2.70221
- Real-World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry
https://onlinelibrary.wiley.com/doi/10.1002/ueg2.70223
- Endoscopic Ultrasonography-Guided Gastroenterostomy Is More Cost Effective Than Surgical Gastrojejunostomy: A Health-Economic Evaluation Alongside a Randomized Trial